Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands: insights from the ETNA-AF-Europe study

Tim A. C. de Vries*, Martin E. W. Hemels, Frank Cools, Harry J. G. M. Crijns, Laetitia Yperzeele, Peter Vanacker, Ivan Blankoff, Patrizio Lancellotti, Georges H. Mairesse, Anne de Veer, Ruben Casado Arroyo, Emmanuel Catez, Michel de Pauw, Thomas Vanassche, Carlo de Asmundis, Paulus Kirchhof, Raffaele De Caterina, Joris R. de Groot, ETNA-AF-Europe principal investigators from Belgium and the Netherlands

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)431-439
Number of pages9
JournalActa Cardiologica
Issue number4
Early online date29 Dec 2020
Publication statusPublished - 4 Jul 2021


  • anticoagulants
  • haemorrhage
  • off-label use
  • clinical trial
  • phase IV
  • stroke
  • thromboembolism

Cite this